PSY156 - QUIDS IN? – A REVIEW OF WHETHER POTENTIAL BLOCKBUSTER SAVINGS FROM BIOSIMILAR ADALIMUMAB SHOULD BE REINVESTED IN OTHER DISEASE AREAS?
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2730
https://www.valueinhealthjournal.com/article/S1098-3015(18)36032-7/fulltext
Title :
PSY156 - QUIDS IN? – A REVIEW OF WHETHER POTENTIAL BLOCKBUSTER SAVINGS FROM BIOSIMILAR ADALIMUMAB SHOULD BE REINVESTED IN OTHER DISEASE AREAS?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)36032-7&doi=10.1016/j.jval.2018.09.2730
First page :
Section Title :
Open access? :
No
Section Order :
2088